Oral Drug S-1 Linked to Longer Survival Than Capecitabine in Metastatic Breast Cancer Study
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
Tag: Metastatic Breast Cancer
Real-World Data Show Trastuzumab Deruxtecan Extends Survival in HER2-Low Metastatic Breast Cancer
A real-world cohort of 126 Chinese patients shows trastuzumab deruxtecan delivers a median 9.1 months of progression-free survival in HER2-low ...
Real-World Data Show Antibody-Drug Conjugate Still Works in Late-Stage Triple-Negative Breast Cancer
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
Oral Giredestrant Combination Nearly Doubles Survival Without Progression in Metastatic Breast Cancer
The phase 3 evERA study found that an all-oral combination of the next-generation estrogen receptor degrader giredestrant and everolimus significantly ...
New Screening Program Tackles Job Worries of Patients With Metastatic Breast Cancer
A pilot program at two New York hospitals embedded employment screening into the electronic health record for patients with metastatic ...
Chemotherapy After Hormone Therapy Fails Leaves Metastatic Breast Cancer Patients With Grim Odds
A study of more than 5,000 US patients with HR-positive/HER2-negative metastatic breast cancer found median survival of only 13.5 months ...
Blood Test Tracks Early Response to Breast Cancer Drug Eribulin in Landmark Trial
The phase II DETECT IVb trial confirms eribulin's efficacy and safety in HER2-negative metastatic breast cancer and shows that early ...
Liposomal Paclitaxel With HER-2 Blockers Shows Strong Real-World Results in Advanced Breast Cancer
A real-world study of 526 patients found that paclitaxel liposome combined with anti-HER-2 targeted therapies delivered median overall survival of ...
HER2-Low Breast Cancer Mirrors HER2-0 in Metastasis Timing but Confers a Survival Edge
A retrospective study of nearly 1,600 patients finds that HER2-low breast cancer behaves like HER2-0 disease in metastatic timing and ...
Your Zip Code May Shape Your Breast Cancer Tumor’s Genetics and Your Survival Odds
A large multi-institution study found that metastatic breast cancer patients in high deprivation neighborhoods had more TP53 mutations, lower use ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!